OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm ; volume:4 ; number:1 ; day:13 ; month:4 ; year:2015 ; pages:1-5 ; date:12.2015
SpringerPlus ; 4, Heft 1 (13.4.2015), 1-5, 12.2015
- Urheber
-
Pedraza, María Isabel
de la Cruz, Carolina
Ruiz, Marina
López-Mesonero, Luis
Martínez, Elena
de Lera, Mercedes
Guerrero, Ángel Luis
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40064-015-0957-z
- URN
-
urn:nbn:de:101:1-2021082106233017274541
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pedraza, María Isabel
- de la Cruz, Carolina
- Ruiz, Marina
- López-Mesonero, Luis
- Martínez, Elena
- de Lera, Mercedes
- Guerrero, Ángel Luis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
Acute treatment of migraine. Breaking the paradigm of monotherapy
Cognitive performance in chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Good news for chronic migraine
Predictors of chronic migraine remission
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Combined Interventional Treatment of Refractory Chronic Migraine
Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
Acute treatment of migraine. Breaking the paradigm of monotherapy
Cognitive performance in chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Good news for chronic migraine
Predictors of chronic migraine remission
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Combined Interventional Treatment of Refractory Chronic Migraine
Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
Acute treatment of migraine. Breaking the paradigm of monotherapy
Cognitive performance in chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Good news for chronic migraine
Predictors of chronic migraine remission
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
Combined Interventional Treatment of Refractory Chronic Migraine